Cargando…

Cancer-cell intrinsic gene expression signatures overcome intratumoural heterogeneity bias in colorectal cancer patient classification

Stromal-derived intratumoural heterogeneity (ITH) has been shown to undermine molecular stratification of patients into appropriate prognostic/predictive subgroups. Here, using several clinically relevant colorectal cancer (CRC) gene expression signatures, we assessed the susceptibility of these sig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dunne, Philip D., Alderdice, Matthew, O'Reilly, Paul G., Roddy, Aideen C., McCorry, Amy M. B., Richman, Susan, Maughan, Tim, McDade, Simon S., Johnston, Patrick G., Longley, Daniel B., Kay, Elaine, McArt, Darragh G., Lawler, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460026/ https://www.ncbi.nlm.nih.gov/pubmed/28561046 http://dx.doi.org/10.1038/ncomms15657

Ejemplares similares

Prospective patient stratification into robust cancer‐cell intrinsic subtypes from colorectal cancer biopsies
por: Alderdice, Matthew, et al.
Publicado: (2018)

Stratified analysis reveals chemokine-like factor (CKLF) as a potential prognostic marker in the MSI-immune consensus molecular subtype CMS1 of colorectal cancer
por: Dunne, Philip D., et al.
Publicado: (2016)

Bcl-xL as a poor prognostic biomarker and predictor of response to adjuvant chemotherapy specifically in BRAF-mutant stage II and III colon cancer
por: Dunne, Philip D., et al.
Publicado: (2018)

Epithelial‐to‐mesenchymal transition signature assessment in colorectal cancer quantifies tumour stromal content rather than true transition
por: McCorry, Amy MB, et al.
Publicado: (2018)

NUQA: Estimating Cancer Spatial and Temporal Heterogeneity and Evolution through Alignment-Free Methods
por: Roddy, Aideen C, et al.
Publicado: (2019)

Identification of Candidate Small-Molecule Therapeutics to Cancer by Gene-Signature Perturbation in Connectivity Mapping
por: McArt, Darragh G., et al.
Publicado: (2011)

Embracing an integromic approach to tissue biomarker research in cancer: Perspectives and lessons learned
por: Li, Gerald, et al.
Publicado: (2017)

Evolutionary genetic algorithm identifies IL2RB as a potential predictive biomarker for immune-checkpoint therapy in colorectal cancer
por: Alderdice, Matthew, et al.
Publicado: (2021)

KRAS mutant colorectal cancer gene signatures identified angiotensin II receptor blockers as potential therapies
por: Wen, Qing, et al.
Publicado: (2016)

A bespoke target selection tool to guide biomarker discovery in tubo-ovarian cancer
por: Beirne, James P., et al.
Publicado: (2022)

Prostate cancer heterogeneity assessment with multi-regional sampling and alignment-free methods
por: Murphy, Ross G, et al.
Publicado: (2020)

QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics
por: O’Reilly, Paul G., et al.
Publicado: (2016)

Impact of Variable RNA-Sequencing Depth on Gene Expression Signatures and Target Compound Robustness: Case Study Examining Brain Tumor (Glioma) Disease Progression
por: Stupnikov, Alexey, et al.
Publicado: (2018)

Translation of tissue-based artificial intelligence into clinical practice: from discovery to adoption
por: Geaney, Alice, et al.
Publicado: (2023)

Particle swarm optimization artificial intelligence technique for gene signature discovery in transcriptomic cohorts
por: Murphy, Ross G., et al.
Publicado: (2022)

Transcriptional Profiling of a Patient-Matched Cohort of Glioblastoma (IDH-Wildtype) for Therapeutic Target and Repurposing Drug Identification
por: Roddy, Aideen C., et al.
Publicado: (2023)

Activation of innate-adaptive immune machinery by poly(I:C) exposes a therapeutic vulnerability to prevent relapse in stroma-rich colon cancer
por: Corry, Shania M, et al.
Publicado: (2022)

Immune status is prognostic for poor survival in colorectal cancer patients and is associated with tumour hypoxia
por: Craig, Stephanie G., et al.
Publicado: (2020)

cudaMap: a GPU accelerated program for gene expression connectivity mapping
por: McArt, Darragh G, et al.
Publicado: (2013)

Investigating the suitability of in vitro cell lines as models for the major subtypes of epithelial ovarian cancer
por: McCabe, Aideen, et al.
Publicado: (2023)

IHC-based subcellular quantification provides new insights into prognostic relevance of FLIP and procaspase-8 in non-small-cell lung cancer
por: Hutchinson, Ryan A, et al.
Publicado: (2017)

Transcriptional upregulation of c-MET is associated with invasion and tumor budding in colorectal cancer
por: Bradley, Conor A., et al.
Publicado: (2016)

Novel deep learning-based solution for identification of prognostic subgroups in liver cancer (Hepatocellular carcinoma)
por: Owens, Alice R., et al.
Publicado: (2021)

Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer
por: Bibby, Becky A. S., et al.
Publicado: (2021)

Transcriptional Subtyping and CD8 Immunohistochemistry Identifies Patients With Stage II and III Colorectal Cancer With Poor Prognosis Who Benefit From Adjuvant Chemotherapy
por: Allen, Wendy L., et al.
Publicado: (2018)

classifieR a flexible interactive cloud-application for functional annotation of cancer transcriptomes
por: Quinn, Gerard P., et al.
Publicado: (2022)

Quality and Performance Improvement: What’s a Program to Do?
por: McCorry, Frank
Publicado: (2007)

Microsoft Exchange Server 2003: Deployment and Migration SP1 and SP2
por: McCorry, Kieran
Publicado: (2006)

Epidermal growth factor receptor immunohistochemistry: new opportunities in metastatic colorectal cancer
por: Hutchinson, Ryan A, et al.
Publicado: (2015)

Connectivity Mapping for Candidate Therapeutics Identification Using Next Generation Sequencing RNA-Seq Data
por: McArt, Darragh G., et al.
Publicado: (2013)

Intratumour microbiome of pancreatic cancer
por: Guan, Shi-Wei, et al.
Publicado: (2023)

Organize your work day-- in no time
por: McCorry, K J
Publicado: (2005)

Overcoming intratumoural heterogeneity for reproducible molecular risk stratification: a case study in advanced kidney cancer
por: Lubbock, Alexander L. R., et al.
Publicado: (2017)

Quantification of HER2 heterogeneity in breast cancer–implications for identification of sub-dominant clones for personalised treatment
por: Buckley, Niamh E., et al.
Publicado: (2016)

Use of parecoxib by continuous subcutaneous infusion for cancer pain in a hospice population
por: Armstrong, Peter, et al.
Publicado: (2018)

RALB GTPase: a critical regulator of DR5 expression and TRAIL sensitivity in KRAS mutant colorectal cancer
por: Khawaja, Hajrah, et al.
Publicado: (2020)

Clinical Positioning of the IAP Antagonist Tolinapant (ASTX660) in Colorectal Cancer
por: Crawford, Nyree, et al.
Publicado: (2021)

Multidimensional intratumour heterogeneity in neuroblastoma
por: von Stedingk, Kristoffer, et al.
Publicado: (2019)

Guide to American English
por: Myers, L. M. (Louis McCorry), 1901-
Publicado: (1962)

Exploring the understanding of best practice approaches to common dog behaviour problems by veterinary professionals in Ireland
por: Shalvey, Emma, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gcjggctl2unptj3jcud6gvskh2